Catalent began a $175 million project to expand its flagship U.S. manufacturing facility for large scale oral dose forms in Winchester, KY. Two new buildings, expected to be completed by January 2024, will add 107,000 sq.-ft. to the site’s manufacturing footprint.   The investment will expand the site’s highly potent material handling capabilities and containment vault, provide additional lab space, and add further capacity for existing operations including dual fill encapsulation and pan coat...